Testing Status of Agents at NTP
Acronycine
CASRN: 7008-42-6
Formula: C20 H19 N O3
Synonyms/Common Names:
- 3,12-DIHYDRO-6-METHOXY-3,3,12-TRIMETHYL-7H-PYRANOL(2,3-C)ACRIDIN-7-ONE (9CI)
Known Uses:
ANTICANCER DRUG
Short-Term Toxicity
- 14-Day (Intraperitoneal Injection)
(C01536) Completed
- NTIS No. PB283347
(Peer Review 03/07/1978)
Citation: Bioassay of Acronycine for Possible Carcinogenicity (CAS No. 7008-42-6) - Rats: Sprague Dawley; Mice: B6C3F1
- NTIS No. PB283347
(Peer Review 03/07/1978)
- 13-Week (Intraperitoneal Injection)
(C01536) Completed
- NTIS No. PB283347
(Peer Review 03/07/1978)
Citation: Bioassay of Acronycine for Possible Carcinogenicity (CAS No. 7008-42-6) - Rats: Sprague Dawley; Mice: B6C3F1
- Dose: MR: 0,1.5,30, M: 0,2.5,50 MG/KG/10 PER GROUP
- NTIS No. PB283347
(Peer Review 03/07/1978)
Long-Term Carcinogenicity
- 2-Year (Intraperitoneal Injection)
(C01536) Report Complete
- TR-049 (NTIS No. PB283347)
(Peer Review 03/07/1978)
Bioassay of Acronycine for Possible Carcinogenicity (CAS No. 7008-42-6) - Rats: Sprague Dawley; Mice: B6C3F1
- Carcinogenesis Results
- Male Rats Positive
- Female Rats Positive
- Male Mice Inadequate Study
- Female Mice Inadequate Study
- Dose: R: 0,3.75,7.5,15, M: 0,2,6,12.5,25 MG/KG/35 PER GROUP
- TR-049 (NTIS No. PB283347)
(Peer Review 03/07/1978)
Web page last updated on January 22, 2009